IMNM Immunome Inc.
Nasdaq · SEC CIK 1472012 · EDGAR
- Bought, last 12 months
- $2.31M 8 purchases by 3 insiders
- Sold, last 12 months
- $27.51M 16 sales by 7 insiders
- Filings on record
- 125 since 2021-08-20, latest 2026-09-15 16:30
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Barchas Isaac | Dir | — | $18.27M |
| Rosett Max | CFO | — | $2.52M |
| Lechleider Robert | Chief Medical Off | — | $2.34M |
| Horn Kinney | Chief BUSINESS Off | — | $2.30M |
| SIEGALL CLAY B | Pres, CEO, Dir | $1.75M | — |
| WAGENHEIM PHILIP | Dir | — | $1.34M |
| BIENAIME JEAN JACQUES | Dir | $351.4K | $203.8K |
| Higgins Jack | CSO | — | $538.5K |
| Tsai Philip | Chief Technical Off | $204.9K | — |
| Stoneman Sandra G. | CLO, GC | — | — |
Transactions 73
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-09-15 16:30 | 2026-09-11 | IMNM | Higgins Jack | CSO | M - OptEx | $1.35 | +18.0K | 78.2K | +30% | +$24.3K |
| DT | 2026-09-15 16:30 | 2026-09-11 | IMNM | Higgins Jack | CSO | S - Sale+OE | $25.32 | -13.2K | 65.0K | -17% | -$334.2K |
| DT | 2026-09-15 16:30 | 2026-09-11 | IMNM | Higgins Jack | CSO | G - Gift | $0.00 | -8,800 | 56.2K | -14% | $0 |
| MTI | 2026-08-12 17:47 | 2026-08-10+ | IMNM | Barchas Isaac | Dir | S - Sale | $26.21 | -72.4K | 0 | -100% | -$1.90M |
| T | 2026-08-12 17:47 | 2026-08-12 | IMNM | Barchas Isaac | Dir | S - Sale | $27.25 | -11.0K | 92.2K | -11% | -$301.1K |
| MTI | 2026-08-10 16:10 | 2026-08-06+ | IMNM | Barchas Isaac | Dir | S - Sale | $26.06 | -36.1K | 72.4K | -33% | -$940.5K |
| DMT | 2026-08-06 18:30 | 2026-08-04 | IMNM | Horn Kinney | Chief BUSINESS Off | M - OptEx | $11.89 | +90.6K | 90.6K | New | +$1.08M |
| DT | 2026-08-06 18:30 | 2026-08-04 | IMNM | Horn Kinney | Chief BUSINESS Off | S - Sale+OE | $25.09 | -90.6K | 0 | -100% | -$2.27M |
| D | 2026-07-27 16:10 | 2026-07-23 | IMNM | Horn Kinney | Chief BUSINESS Off | A - Grant | $0.00 | +31.2K | 31.2K | New | $0 |
| D | 2026-07-27 16:10 | 2026-07-23 | IMNM | Tsai Philip | Chief Technical Off | A - Grant | $0.00 | +38.2K | 81.5K | +88% | $0 |
| D | 2026-07-27 16:10 | 2026-07-23 | IMNM | Stoneman Sandra G. | CLO, GC | A - Grant | $0.00 | +38.2K | 43.8K | +689% | $0 |
| D | 2026-07-27 16:10 | 2026-07-23 | IMNM | Higgins Jack | CSO | A - Grant | $0.00 | +38.2K | 60.2K | +174% | $0 |
| D | 2026-07-27 16:10 | 2026-07-23 | IMNM | Rosett Max | CFO | A - Grant | $0.00 | +47.2K | 101.3K | +87% | $0 |
| D | 2026-07-27 16:10 | 2026-07-23 | IMNM | Lechleider Robert | Chief Medical Off | A - Grant | $0.00 | +54.0K | 69.8K | +342% | $0 |
| D | 2026-07-27 16:10 | 2026-07-23 | IMNM | SIEGALL CLAY B | Pres, CEO, Dir | A - Grant | $0.00 | +180.0K | 870.7K | +26% | $0 |
| DT | 2026-07-09 17:38 | 2026-07-07 | IMNM | Horn Kinney | Chief BUSINESS Off | M - OptEx | $12.92 | +1,092 | 1,092 | New | +$14.1K |
| DT | 2026-07-09 17:38 | 2026-07-07 | IMNM | Horn Kinney | Chief BUSINESS Off | S - Sale+OE | $25.00 | -1,092 | 0 | -100% | -$27.3K |
| MTI | 2026-07-07 19:02 | 2026-07-06+ | IMNM | Barchas Isaac | Dir | S - Sale | $24.13 | -100.0K | 108.5K | -48% | -$2.41M |
| DT | 2026-07-07 17:42 | 2026-07-02 | IMNM | Lechleider Robert | Chief Medical Off | M - OptEx | $8.73 | +55.0K | 70.8K | +348% | +$480.1K |
| DMT | 2026-07-07 17:42 | 2026-07-02 | IMNM | Lechleider Robert | Chief Medical Off | S - Sale+OE | $22.62 | -55.0K | 15.8K | -78% | -$1.24M |
| MTI | 2026-07-02 20:31 | 2026-06-30+ | IMNM | Barchas Isaac | Dir | S - Sale | $21.85 | -201.1K | 208.5K | -49% | -$4.39M |
| DT | 2026-06-29 16:52 | 2026-06-25 | IMNM | Lechleider Robert | Chief Medical Off | M - OptEx | $8.73 | +55.0K | 70.8K | +348% | +$480.1K |
| DMT | 2026-06-29 16:52 | 2026-06-25 | IMNM | Lechleider Robert | Chief Medical Off | S - Sale+OE | $19.85 | -55.0K | 15.8K | -78% | -$1.09M |
| DT | 2026-06-17 17:26 | 2026-06-15 | IMNM | Rosett Max | CFO | M - OptEx | $1.05 | +60.0K | 114.0K | +111% | +$63.0K |
| DT | 2026-06-17 17:26 | 2026-06-15 | IMNM | Rosett Max | CFO | S - Sale+OE | $18.23 | -60.0K | 54.0K | -53% | -$1.09M |
| M | 2026-06-09 17:40 | 2026-06-05 | IMNM | BIENAIME JEAN JACQUES | Dir | S - Sale | $19.41 | -10.5K | 32.9K | -24% | -$203.8K |
| M | 2026-06-09 17:40 | 2026-06-05 | IMNM | BIENAIME JEAN JACQUES | Dir | P - Purchase | $19.45 | +10.5K | 43.4K | +32% | +$204.3K |
| 2026-05-19 07:56 | 2026-05-15 | IMNM | BIENAIME JEAN JACQUES | Dir | P - Purchase | $20.70 | +5,000 | 43.4K | +13% | +$103.5K | |
| T | 2026-04-03 19:48 | 2026-04-02 | IMNM | Higgins Jack | CSO | S - Sale | $21.64 | -9,438 | 22.0K | -30% | -$204.2K |
| DMT | 2026-04-03 19:46 | 2026-04-02 | IMNM | Rosett Max | CFO | M - OptEx | $1.22 | +71.6K | 119.0K | +151% | +$87.1K |
| DMT | 2026-04-03 19:46 | 2026-04-02 | IMNM | Rosett Max | CFO | S - Sale+OE | $21.92 | -65.0K | 54.0K | -55% | -$1.42M |
| 2026-04-01 17:39 | 2026-03-30 | IMNM | Higgins Jack | CSO | G - Gift | $0.00 | -6,291 | 31.4K | -17% | $0 | |
| 2026-03-31 | 2026-03-27 | IMNM | SIEGALL CLAY B | Pres, CEO, Dir | P - Purchase | $19.67 | +25.4K | 690.7K | +4% | +$500.6K | |
| M | 2026-03-23 | 2026-03-20+ | IMNM | WAGENHEIM PHILIP | Dir | S - Sale | $20.55 | -65.0K | 369.3K | -15% | -$1.34M |
| M | 2026-03-12 | 2026-03-10+ | IMNM | BIENAIME JEAN JACQUES | Dir | P - Purchase | $21.84 | +2,000 | 38.4K | +5% | +$43.7K |
| 2025-12-30 | 2025-12-30 | IMNM | SIEGALL CLAY B | Pres, CEO, Dir | P - Purchase | $21.15 | +4,729 | 665.3K | +0.7% | +$100.0K | |
| MI | 2025-12-23 | 2025-12-22 | IMNM | Barchas Isaac | Dir | S - Sale | $21.74 | -383.2K | 2.03M | -16% | -$8.33M |
| 2025-12-22 | 2025-12-19 | IMNM | Tsai Philip | Chief Technical Off | P - Purchase | $20.49 | +10.0K | 43.3K | +30% | +$204.9K | |
| 2025-12-22 | 2025-12-19 | IMNM | SIEGALL CLAY B | Pres, CEO, Dir | G - Gift | $0.00 | -200.0K | 660.5K | -23% | $0 | |
| 2025-12-22 | 2025-12-19 | IMNM | SIEGALL CLAY B | Pres, CEO, Dir | P - Purchase | $20.48 | +7,278 | 860.5K | +0.9% | +$149.1K | |
| MI | 2025-12-22 | 2025-12-19 | IMNM | Higgins Jack | CSO | G - Gift | $0.00 | +3,000 | 1,000 | New | $0 |
| M | 2025-12-22 | 2025-12-19 | IMNM | Higgins Jack | CSO | G - Gift | $0.00 | -3,000 | 38.7K | -7% | $0 |
| 2025-12-18 | 2025-12-18 | IMNM | SIEGALL CLAY B | Pres, CEO, Dir | P - Purchase | $21.50 | +46.5K | 853.2K | +6% | +$1000.0K | |
| D | 2025-09-11 | 2025-09-10 | IMNM | Higgins Jack | CSO | M - OptEx | $1.35 | +22.0K | 40.7K | +117% | +$29.7K |
| 2025-06-03 | 2025-06-03 | IMNM | BIENAIME JEAN JACQUES | Dir | P - Purchase | $9.38 | +5,000 | 36.4K | +16% | +$46.9K | |
| D | 2025-03-28 | 2025-03-27 | IMNM | Higgins Jack | CSO | M - OptEx | $1.35 | +5,200 | 18.7K | +38% | +$7,020 |
| 2025-03-26 | 2025-03-25 | IMNM | BIENAIME JEAN JACQUES | Dir | P - Purchase | $7.78 | +7,800 | 31.4K | +33% | +$60.7K | |
| 2025-03-26 | 2025-03-26 | IMNM | SIEGALL CLAY B | Pres, CEO, Dir | P - Purchase | $7.29 | +137.1K | 806.7K | +20% | +$999.5K | |
| 2025-03-25 | 2025-03-24 | IMNM | Tsai Philip | CTO | P - Purchase | $8.42 | +12.3K | 33.3K | +59% | +$103.6K | |
| 2025-03-25 | 2025-03-24 | IMNM | BIENAIME JEAN JACQUES | Dir | P - Purchase | $8.21 | +7,000 | 23.6K | +42% | +$57.5K | |
| 2025-02-03 | 2025-01-31 | IMNM | SIEGALL CLAY B | Pres, CEO, Dir | P - Purchase | $7.75 | +150.0K | 669.6K | +29% | +$1.16M | |
| 2024-11-25 | 2024-11-21 | IMNM | Lechleider Robert | Chief Medical Off | P - Purchase | $9.48 | +15.8K | 15.8K | New | +$149.8K | |
| M | 2024-11-25 | 2024-11-21+ | IMNM | SIEGALL CLAY B | Pres, CEO, Dir | P - Purchase | $9.62 | +100.0K | 519.6K | +24% | +$962.1K |
| 2024-11-25 | 2024-11-21 | IMNM | Tsai Philip | CTO | P - Purchase | $9.43 | +21.0K | 21.0K | New | +$198.0K | |
| D | 2024-09-20 | 2024-09-19 | IMNM | Rosett Max | CFO | S - Sale+OE | $16.01 | -14.4K | 47.5K | -23% | -$230.2K |
| D | 2024-09-20 | 2024-09-19 | IMNM | Rosett Max | CFO | M - OptEx | $1.05 | +42.0K | 61.9K | +212% | +$44.1K |
| 2024-08-19 | 2024-08-16 | IMNM | BIENAIME JEAN JACQUES | Dir | P - Purchase | $13.94 | +7,000 | 16.6K | +73% | +$97.6K | |
| D | 2024-08-19 | 2024-08-15 | IMNM | Higgins Jack | CSO | S - Sale+OE | $13.93 | -3,524 | 16.0K | -18% | -$49.1K |
| D | 2024-08-19 | 2024-08-19 | IMNM | Higgins Jack | CSO | G - Gift | $0.00 | -2,471 | 13.5K | -15% | $0 |
| D | 2024-08-19 | 2024-08-15 | IMNM | Higgins Jack | CSO | M - OptEx | $1.35 | +19.5K | 19.5K | New | +$26.4K |
| 2024-05-22 | 2024-05-21 | IMNM | BIENAIME JEAN JACQUES | Dir | P - Purchase | $13.57 | +2,000 | 9,615 | +26% | +$27.1K | |
| M | 2024-05-21 | 2024-05-20+ | IMNM | SIEGALL CLAY B | Pres, CEO, Dir | P - Purchase | $13.88 | +100.0K | 419.6K | +31% | +$1.39M |
| D | 2023-10-04 | 2023-10-02 | IMNM | PRENDERGAST FRANKLYN G | Dir | A - Grant | $0.00 | +60.8K | 60.8K | New | $0 |
| 2023-10-04 | 2023-10-02 | IMNM | Turner Bruce | Chief Strategy Off | P - Purchase | $5.91 | +42.3K | 42.3K | New | +$250.0K | |
| 2023-10-04 | 2023-10-02 | IMNM | SIEGALL CLAY B | Pres, CEO, Dir | P - Purchase | $5.91 | +169.2K | 319.6K | +112% | +$1000.0K | |
| 2023-10-03 | 2023-10-02 | IMNM | RAPP MICHAEL | Dir | A - Grant | $5.91 | +253.8K | 1.07M | +31% | +$1.50M | |
| 2023-01-17 | 2023-01-15 | IMNM | RAPP MICHAEL | Dir | A - Grant | $4.00 | +17.5K | 817.4K | +2% | +$70.0K | |
| 2023-01-17 | 2023-01-15 | IMNM | LAMATTINA JOHN L | Dir | A - Grant | $4.00 | +15.1K | 67.0K | +29% | +$60.5K | |
| 2023-01-17 | 2023-01-15 | IMNM | Lefenfeld Michael | Dir | A - Grant | $4.00 | +13.9K | 40.7K | +52% | +$55.5K | |
| 2023-01-17 | 2023-01-15 | IMNM | WAGENHEIM PHILIP | Dir | A - Grant | $4.00 | +8,750 | 406.1K | +2% | +$35.0K | |
| I | 2021-09-14 | 2021-09-13 | IMNM | RAPP MICHAEL | Dir | P - Purchase | $19.96 | +26.0K | 208.7K | +14% | +$518.2K |
| MI | 2021-09-13 | 2021-09-09+ | IMNM | RAPP MICHAEL | Dir | P - Purchase | $18.07 | +46.0K | 145.0K | +46% | +$830.4K |
| D | 2021-08-20 | 2021-08-18 | IMNM | BARON RICHARD A | Dir | M - OptEx | $11.38 | +2,343 | 2,343 | New | +$26.7K |
Purchase Sale Sale after option exercise All abbreviations